Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

January 31, 2015

Study Completion Date

April 30, 2015

Conditions
Ependymoma
Interventions
DRUG

Carboplatin

Patients will receive daily carboplatin as a radiation sensitizer prior to radiation each day.

Trial Locations (1)

60614

Children's Memorial Hospital, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Brown University

OTHER

lead

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER